US Stock MarketDetailed Quotes

LXEO Lexeo Therapeutics

Watchlist
  • 6.280
  • +0.240+3.97%
Close Dec 20 16:00 ET
  • 6.280
  • 0.0000.00%
Post 16:20 ET
207.65MMarket Cap-2.40P/E (TTM)

Lexeo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
-60.53%654K
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
-60.53%654K
--0
Cost of revenue
Gross profit
Operating expense
55.59%31.54M
68.52%23.55M
20.74%23.29M
12.02%68.51M
-1.47%14.97M
12.55%20.27M
-8.95%13.98M
19.29M
16.96%61.16M
15.2M
Selling and administrative expenses
168.25%8.12M
155.20%6.99M
164.69%7.55M
28.18%15.38M
77.53%6.76M
14.18%3.03M
-11.10%2.74M
--2.85M
67.31%12M
--3.81M
-General and administrative expense
168.25%8.12M
155.20%6.99M
164.69%7.55M
28.18%15.38M
77.53%6.76M
14.18%3.03M
-11.10%2.74M
--2.85M
67.31%12M
--3.81M
Research and development costs
35.82%23.42M
47.38%16.56M
-4.23%15.74M
8.07%53.13M
-27.90%8.21M
12.26%17.25M
-8.40%11.24M
--16.44M
8.96%49.16M
--11.39M
Operating profit
-55.59%-31.54M
-68.52%-23.55M
-20.74%-23.29M
-13.23%-68.51M
1.47%-14.97M
-15.96%-20.27M
8.73%-13.98M
-19.29M
-19.50%-60.51M
-15.2M
Net non-operating interest income expense
371.79%2.06M
330.73%2.31M
153.38%1.61M
115.72%2.66M
69.13%1.05M
2.11%436K
219.64%537K
637K
8,126.67%1.23M
622K
Non-operating interest income
328.69%2.09M
297.97%2.35M
140.32%1.65M
116.38%2.87M
63.02%1.1M
7.02%488K
233.33%590K
--687K
8,733.33%1.33M
--676K
Non-operating interest expense
-32.69%35K
-33.96%35K
-26.00%37K
125.27%205K
-7.41%50K
79.31%52K
488.89%53K
--50K
--91K
--54K
Other net income (expense)
98.89%-3K
66.67%-1K
-25.00%-5K
-27,050.00%-543K
-265K
-271K
-3K
-4K
-2K
Gain on sale of security
----
----
----
---530K
---258K
---272K
----
----
----
----
Other non- operating income (expenses)
-400.00%-3K
66.67%-1K
-25.00%-5K
-550.00%-13K
---7K
--1K
---3K
---4K
---2K
----
Income before tax
-46.65%-29.49M
-58.01%-21.24M
-16.21%-21.68M
-12.01%-66.39M
2.68%-14.19M
-17.90%-20.11M
11.24%-13.44M
-18.66M
-17.10%-59.28M
-14.58M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-46.65%-29.49M
-58.01%-21.24M
-16.21%-21.68M
-12.01%-66.39M
2.68%-14.19M
-17.90%-20.11M
11.24%-13.44M
-18.66M
-17.10%-59.28M
-14.58M
Net income continuous Operations
-46.65%-29.49M
-58.01%-21.24M
-16.21%-21.68M
-12.01%-66.39M
2.68%-14.19M
-17.90%-20.11M
11.24%-13.44M
---18.66M
-17.10%-59.28M
---14.58M
Minority interest income
Net income attributable to the parent company
-46.65%-29.49M
-58.01%-21.24M
-16.21%-21.68M
-12.01%-66.39M
2.68%-14.19M
-17.90%-20.11M
11.24%-13.44M
-18.66M
-17.10%-59.28M
-14.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-46.65%-29.49M
-58.01%-21.24M
-16.21%-21.68M
-12.01%-66.39M
2.68%-14.19M
-17.90%-20.11M
11.24%-13.44M
-18.66M
-17.10%-59.28M
-14.58M
Basic earnings per share
-11.40%-0.89
-19.85%-0.64
-3.88%-0.77
-426.51%-12.4
8.07%-0.5324
-17.90%-0.7989
11.24%-0.534
-0.7413
-17.10%-2.3551
-0.5792
Diluted earnings per share
-11.40%-0.89
-19.85%-0.64
-3.88%-0.77
-426.51%-12.4
8.07%-0.5324
-17.90%-0.7989
11.24%-0.534
-0.7413
-17.10%-2.3551
-0.5792
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 00000000-60.53%654K0
Operating revenue --0--0--0--0--0--0--0--0-60.53%654K--0
Cost of revenue
Gross profit
Operating expense 55.59%31.54M68.52%23.55M20.74%23.29M12.02%68.51M-1.47%14.97M12.55%20.27M-8.95%13.98M19.29M16.96%61.16M15.2M
Selling and administrative expenses 168.25%8.12M155.20%6.99M164.69%7.55M28.18%15.38M77.53%6.76M14.18%3.03M-11.10%2.74M--2.85M67.31%12M--3.81M
-General and administrative expense 168.25%8.12M155.20%6.99M164.69%7.55M28.18%15.38M77.53%6.76M14.18%3.03M-11.10%2.74M--2.85M67.31%12M--3.81M
Research and development costs 35.82%23.42M47.38%16.56M-4.23%15.74M8.07%53.13M-27.90%8.21M12.26%17.25M-8.40%11.24M--16.44M8.96%49.16M--11.39M
Operating profit -55.59%-31.54M-68.52%-23.55M-20.74%-23.29M-13.23%-68.51M1.47%-14.97M-15.96%-20.27M8.73%-13.98M-19.29M-19.50%-60.51M-15.2M
Net non-operating interest income expense 371.79%2.06M330.73%2.31M153.38%1.61M115.72%2.66M69.13%1.05M2.11%436K219.64%537K637K8,126.67%1.23M622K
Non-operating interest income 328.69%2.09M297.97%2.35M140.32%1.65M116.38%2.87M63.02%1.1M7.02%488K233.33%590K--687K8,733.33%1.33M--676K
Non-operating interest expense -32.69%35K-33.96%35K-26.00%37K125.27%205K-7.41%50K79.31%52K488.89%53K--50K--91K--54K
Other net income (expense) 98.89%-3K66.67%-1K-25.00%-5K-27,050.00%-543K-265K-271K-3K-4K-2K
Gain on sale of security ---------------530K---258K---272K----------------
Other non- operating income (expenses) -400.00%-3K66.67%-1K-25.00%-5K-550.00%-13K---7K--1K---3K---4K---2K----
Income before tax -46.65%-29.49M-58.01%-21.24M-16.21%-21.68M-12.01%-66.39M2.68%-14.19M-17.90%-20.11M11.24%-13.44M-18.66M-17.10%-59.28M-14.58M
Income tax 0000000000
Net income -46.65%-29.49M-58.01%-21.24M-16.21%-21.68M-12.01%-66.39M2.68%-14.19M-17.90%-20.11M11.24%-13.44M-18.66M-17.10%-59.28M-14.58M
Net income continuous Operations -46.65%-29.49M-58.01%-21.24M-16.21%-21.68M-12.01%-66.39M2.68%-14.19M-17.90%-20.11M11.24%-13.44M---18.66M-17.10%-59.28M---14.58M
Minority interest income
Net income attributable to the parent company -46.65%-29.49M-58.01%-21.24M-16.21%-21.68M-12.01%-66.39M2.68%-14.19M-17.90%-20.11M11.24%-13.44M-18.66M-17.10%-59.28M-14.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -46.65%-29.49M-58.01%-21.24M-16.21%-21.68M-12.01%-66.39M2.68%-14.19M-17.90%-20.11M11.24%-13.44M-18.66M-17.10%-59.28M-14.58M
Basic earnings per share -11.40%-0.89-19.85%-0.64-3.88%-0.77-426.51%-12.48.07%-0.5324-17.90%-0.798911.24%-0.534-0.7413-17.10%-2.3551-0.5792
Diluted earnings per share -11.40%-0.89-19.85%-0.64-3.88%-0.77-426.51%-12.48.07%-0.5324-17.90%-0.798911.24%-0.534-0.7413-17.10%-2.3551-0.5792
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List